hear.com Unveils Next-Gen Addition to Horizon AX Hearing Aid Line

hear.com, the world’s largest online provider of expert, medical-grade hearing care, today announced the launch of its new hearing aid line, the Horizon AX, enhancing its already robust product portfolio. In support of hear.com’s mission to bring high-quality hearing care to anyone, anywhere, the new family of hearing aids are for those seeking an affordable, easy-to-use solution that provides the most advanced sound experience possible.

Nearly 2.5 billion people are projected to have some degree of hearing loss globally by 2050, yet there is a gap in hearing care driven by both limited affordability and access to quality devices, along with the perceived stigma of hearing aids. When combined with hear.com’s two-tier case management approach, the new Horizon AX line goes a long way toward addressing the root causes of subpar hearing care and acceptability. The hear.com Horizon AX hearing aid line boasts an elite, revolutionary sound experience not found in any other hearing devices on the market today. The stylish design offers discrete placement and provides users with excellent speech understanding, built-in situation detection technology, and bespoke features specifically for the more active user, including:

  • Speech Focus Mode provides an extra boost of crystal-clear speech comprehension by identifying and suppressing background noise in real time – allowing the user to focus on one-on-one conversations even in noisy environments like restaurants, sporting events, conferences, etc.
  • Panorama Mode boosts sound clarity in a 360-degree radius around the user, ensuring clear and realistic comprehension from every direction.
  • Relax Mode mutes microphones at the touch of a button and emits serene, stress-relieving ocean sounds.

Horizon AX products also make it possible to clear speech understanding, combining the most innovative technology with the experience of over three million customer consultations. Using two separate processors, this state-of-the-art technology significantly increases the contrast between speech and background noise, making speech more easily understandable and accentuating frequencies at the user’s fingertips.

“The best hearing aid we’ve ever sold,” hear.com’s Horizon AX seamlessly connects users to the world. All devices come with Bluetooth connection, rechargeable batteries, and direct integration with both Apple iPhone and Android products. The Horizon smartphone app for simple, discreet hearing care management allows users to access music, telephone calls, podcasts and even TV with the Streamline TV feature.

Featuring three unique styles – the Style, Go and Mini – the Horizon AX line is designed to offer cutting-edge technology without compromising style or comfort. The line is available in multiple colors with a sleek behind-the-ear style and will be available as  in-the-canal hearing aids later this year.

The hear.com Horizon AX is available to be fit today either via a hand-selected hear.com partner audiologist or the company’s Tele-Audiology option. hear.com’s Clinic-in-a-Box™ Tele-Audiology journey delivers a package including a tablet, hearing aids, and all diagnostic equipment needed to conduct a high-quality medical hearing evaluation and fitting of hearing devices, right to your doorstep, and is proven to deliver superior outcomes versus in-clinic fittings.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.